-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

VelociSuite: Leveraging Regeneron’s Technologies to Produce an Innovative Therapeutic Pipeline

Sponsor: Regeneron Pharmaceuticals, Inc
Program: Industry Theaters
Monday, December 12, 2022: 12:15 PM-1:15 PM
Hall J - Theater 3 (Ernest N. Morial Convention Center)
Sarah Hatsell, PhD, Regeneron Pharmaceuticals, Inc. and David Dilillo, PhD, Regeneron Pharmaceuticals, Inc.
No relevant conflicts of interest to declare.
For in-person participants only
See more of: Industry Theaters